Annuncio pubblicitario
Italia markets open in 58 minutes
  • Dow Jones

    37.735,11
    -248,13 (-0,65%)
     
  • Nasdaq

    15.885,02
    -290,08 (-1,79%)
     
  • Nikkei 225

    38.526,71
    -706,09 (-1,80%)
     
  • EUR/USD

    1,0621
    -0,0005 (-0,04%)
     
  • Bitcoin EUR

    59.082,11
    -2.611,84 (-4,23%)
     
  • CMC Crypto 200

    885,54
    0,00 (0,00%)
     
  • HANG SENG

    16.341,88
    -258,58 (-1,56%)
     
  • S&P 500

    5.061,82
    -61,59 (-1,20%)
     

Is Longeveron a Good Biotech Stock to Buy?

Is Longeveron a Good Biotech Stock to Buy?

An American biotechnology company located in Miami of all places has convinced more than a few investors that its cellular therapy candidate can reverse common effects of aging. This November, shares of Longeveron (NASDAQ: LGVN) shot up more than 10-fold. Investors who missed the boat the first time around are wondering if Longeveron the recent slide is an opportunity to buy a potential long-term winner at a relative discount.